No abstract

No abstract

The hip joint helps the upper body to transfer its weight to lower body. A Wear between the joints is the primary cause of the hip implant becoming loose. The wear can occur due to various reasons. Due to this revision surgery are most common in young and active patients. In the design phase of the implant if this is taken care then life expectancy of the implant can be improved. Small design changes can significantly enhance the implant's life. In this work, elliptical shaped hip implant stem is designed, and linear wear is estimated at trunnion junction. In this work, a 28 mm diameter femoral head with a 4 mm thick acetabular cup and a 2 mm thick backing cup is used. The top surface taper radiuses are changed. Solid works was used to create the models. Ansys was used to perform the analysis. It was found that as the radius of the TTR decreased, the wear rate decreased. The least wear rate was found in 12/14 mm taper with a value of 1.15E-02 mm/year for the first material combination and with a value of 1.23E -02 mm/year for the second material combination. In the comparison between the models with 1 mm chamfer and no chamfer, it was found that the wear rate was lower for the models with 1 mm chamfer. When the chamfer was increased (more than 1 mm), the linear wear increased. Wear is the main reason for loosening of hip implant, which leads to a revision of an implant. It was found that with a decrease in TTR, there was a small increase in the linear wear rate. Overall, the implant with TTR 6mm and a chamfer of 1 mm was found to have the least wear rate.

No abstract

Objective: Low-level laser therapy (also known as photobiomodulation therapy, PBMT) promotes accelerated healing of diabetic foot ulcers (DFUs), thereby preventing the risk of future complications and amputation. The aim of this study was to determine the effect of PBMT, with structured, graded mobilisation and foot care, on DFU healing dynamics. Method: Patients diagnosed with type 2 diabetes, diabetic peripheral neuropathy and presenting with a chronic neuroischaemic DFU, were treated with PBMT using scanning and non-contact probe methods. The DFU was clinically observed and the area measured every seven days until complete healing. Neuropathic parameters were also measured. The PBMT was administered until complete closure of the DFU and patients also undertook a programme of graded mobilisation. Results: A total of 17 participants were recruited, with a mean age of 69±8 years, and a mean duration of diabetes of 13±5 years. Mean complete closure time was 26±11days. In addition, a mean reduction of the semi-quantitative vibration pressure threshold from 49±2 volts to 20±4 volts was observed in all participants. Conclusion: PBMT can be effectively used as a treatment mode for neuroischaemic DFUs in patients with type 2 diabetes. Graded mobilisation with focused foot care could improve the function of people living with type 2 diabetes with a chronic DFU.